Professional Medical Expertise Company (TADAWUL:9574)

TADAWUL:9574 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	295	340	315	250	-	-
Market Cap Growth	-11.16%	7.90%	25.73%	-	-	-
Enterprise Value	417	443	409	321	-	-
Last Close Price	84.40	97.00	88.85	67.81	-	-
PE Ratio	7.08	8.14	11.38	10.07	-	-
PS Ratio	0.71	0.81	1.00	1.00	-	-
PB Ratio	1.97	2.26	2.78	2.58	-	-
P/TBV Ratio	1.97	2.26	2.78	2.58	-	-
P/OCF Ratio	412.98	474.63	-	42.56	-	-
EV/Sales Ratio	1.00	1.06	1.31	1.29	-	-
EV/EBITDA Ratio	6.10	6.71	9.24	8.68	-	-
EV/EBIT Ratio	6.98	7.42	10.38	9.72	-	-
Debt / Equity Ratio	0.84	0.84	0.83	0.66	0.80	0.95
Debt / EBITDA Ratio	1.84	1.84	2.04	1.67	2.02	1.41
Debt / FCF Ratio	-	-	-	-	-	2.14
Net Debt / Equity Ratio	0.81	0.81	0.79	0.65	0.73	0.51
Net Debt / EBITDA Ratio	1.85	1.85	2.01	1.71	1.90	0.77
Net Debt / FCF Ratio	-5.18	-5.18	-10.52	-20.46	-5.10	1.14
Asset Turnover	1.13	1.13	1.04	1.05	0.97	0.94
Inventory Turnover	1.57	1.57	1.34	1.48	1.52	1.55
Quick Ratio	0.90	0.90	0.73	0.81	0.90	0.90
Current Ratio	1.55	1.55	1.57	1.53	1.59	1.33
Return on Equity (ROE)	31.66%	31.66%	26.28%	29.16%	33.67%	64.79%
Return on Assets (ROA)	10.04%	10.04%	8.19%	8.64%	8.89%	10.91%
Return on Invested Capital (ROIC)	20.06%	23.02%	19.99%	21.03%	25.34%	40.15%
Return on Capital Employed (ROCE)	35.60%	35.60%	31.00%	30.60%	31.80%	53.60%
Earnings Yield	14.12%	12.29%	8.79%	9.93%	-	-
FCF Yield	-7.96%	-6.93%	-2.69%	-1.24%	-	-
Dividend Yield	1.18%	-	1.13%	-	-	-
Payout Ratio	8.39%	8.39%	36.08%	-	84.14%	14.06%
Buyback Yield / Dilution	-	-	-	-56.73%	-189.51%	-
Total Shareholder Return	1.18%	-	1.13%	-56.73%	-189.51%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.